Methylphenidate in Treatment of ADHD and Comorbid Chronic Tic Disorder
The safety and efficacy of immediate-release methylphenidate (MPH-IR) for the treatment of attention deficit hyperactivity disorder (ADHD) in children (ages 6-12 years) with Tourette's syndrome (96%) or chronic motor tic disorder (4%) were evaluated at State University of New York, Stony Brook.
Tallennettuna:
| Päätekijä: | |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Pediatric Neurology Briefs Publishers
2007-07-01
|
| Sarja: | Pediatric Neurology Briefs |
| Aiheet: | |
| Linkit: | https://www.pediatricneurologybriefs.com/articles/1010 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|